Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
McKesson
Deloitte
Colorcon
Daiichi Sankyo
US Department of Justice
Argus Health
Medtronic
Cantor Fitzgerald

Generated: January 19, 2019

DrugPatentWatch Database Preview

Details for Patent: 5,674,895

« Back to Dashboard

Summary for Patent: 5,674,895
Title: Dosage form comprising oxybutynin
Abstract:A composition comprising oxybutynin and a device comprising oxybutynin are disclosed for oxybutynin therapy.
Inventor(s): Guittard; George V. (Cupertino, CA), Jao; Francisco (San Jose, CA), Marks; Susan M. (San Jose, CA), Kidney; David J. (Sunnyvale, CA), Gumucio; Fernando (Santa Clara, CA)
Assignee: Alza Corporation (Palo Alto, CA)
Application Number:08/445,849
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Delivery; Device;

Drugs Protected by US Patent 5,674,895

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 5,674,895

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 5639296 ➤ Try a Free Trial
Australia 695194 ➤ Try a Free Trial
Australia 718849 ➤ Try a Free Trial
Australia 9052298 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Deloitte
Mallinckrodt
Express Scripts
QuintilesIMS
Chubb
Citi
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.